ANDA 76959, held by Sandoz. Carboplatin.
As of Nov 15, 2026, ANDA 76959 (Carboplatin), held by Sandoz, was first approved by FDA on Mar 18, 2005, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 18, 2005 | Original application | Approved | None posted |
| Carboplatin50MG/VIAL · injectable;injection | Carboplatin | Discontinued |
| Carboplatin150MG/VIAL · injectable;injection | Carboplatin | Discontinued |
| Carboplatin450MG/VIAL · injectable;injection | Carboplatin | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
